IBM, Coriell, CareKinesis Collaborate to Enhance Medication Safety for Elderly | GenomeWeb

NEW YORK (GenomeWeb) – IBM today announced a collaboration with Coriell Life Sciences and CareKinesis to analyze and store genetic data from elderly patients in an effort to improve and better manage their medication regimens.

Using SoftLayer, an IBM company, the partners are launching an initiative with Program for All Inclusive Care of the Elderly (PACE) "to enhance medication safety by better understanding how high-risk individuals respond to specific medications and drug treatments," they said in a statement. PACE cares for about 5,000 seniors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: Neanderthal-derived DNA linked to modern ailments, and more.

Japan needs to catch up on its gene-editing research efforts, the Japan News writes.

Hundreds of people have signed an online petition calling for zero tolerance to sexual harassment in the sciences.

Jeff Huber, former Google X senior vice president, joins Grail as its CEO.

Feb
25
Sponsored by
Omicia

This webinar will demonstrate how ACMG's recommended variant scoring and classification rules may be applied to standardize reporting on sequencing test results within and across institutions.